In the most recent buying and selling session, Genesis Healthcare (GEN) closed at $1.52, marking no
In the most recent buying and selling session, Genesis Healthcare (GEN) closed at $1.52, marking no change from the day past. This variation was narrower than the S&P 500’s each day lack of 0.39%. In the meantime, the Dow misplaced 0.95%, and the Nasdaq, a tech-heavy index, misplaced 0.83%.
Heading into at this time, shares of the operator of nursing properties and senior dwelling communities had gained 12.59% over the previous month, outpacing the Medical sector’s lack of 1.06% and the S&P 500’s lack of 0.1% in that point.
Wall Road shall be searching for positivity from GEN because it approaches its subsequent earnings report date. On that day, GEN is projected to report earnings of -$0.10 per share, which might characterize year-over-year development of 68.75%. In the meantime, our newest consensus estimate is looking for income of $1.13 billion, down 7.17% from the prior-year quarter.
Trying on the full 12 months, our Zacks Consensus Estimates counsel analysts expect earnings of -$0.46 per share and income of $4.55 billion. These totals would mark modifications of +70.32% and -8.6%, respectively, from final 12 months.
…